Sunfox Bags Rs 15 crore in Pre-series Funding For Cardiac Innovations

Sunfox Technologies, the health tech startup known for its participation on Shark Tank India, has secured an extra Rs 15 crore in a pre-series funding phase. Existing investor Venture Catalyst led the round, with new investors including Finvolve via the IA Growth Opportunities Fund I and Brew Opportunities Fund, as well as Universal Group, KP Singhvi Group, and various high-net-worth individuals (HNIs). This additional funding adds to the previous Rs 5 crore investment by USAID through SAMRIDH Health and LetsVenture, increasing the total raised in this round to Rs. 200 million.

Sunfox is prepared for fast growth in India and worldwide with the help of the fresh capital, concentrating on expanding its main innovation, Spandan. Spandan is a portable ECG device that uses a smartphone to provide users with clinically accurate 12-lead ECG readings, enabling them to detect heart attacks and monitor cardiac health in real time. Spandan has been utilized by more than 30,000 people in 20 countries and has already prevented over 10,000 deaths by detecting heart conditions early. This technology is essential as India faces a rise in heart attacks following the Covid-19 pandemic.

Sunfox, based in Dehradun, a Tier 2 city, is challenging the conventional wisdom that only metropolitan cities produce groundbreaking health tech advancements. The company has built a state-of-the-art in-house research and development center and manufacturing facility in the mountainous state, attracting global interest from renowned institutions like Oxford and Wharton.